End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
39.53 CNY | -0.55% | -5.95% | -35.90% |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-35.90% | 685M | - | ||
+3.08% | 104B | A- | ||
-10.06% | 61.03B | A- | ||
+72.86% | 47.64B | B | ||
+17.31% | 39.24B | B | ||
+4.35% | 32.09B | A- | ||
+15.25% | 20.39B | B- | ||
+13.81% | 16.85B | C+ | ||
+11.47% | 14.28B | B- | ||
-0.10% | 13.88B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- 688275 Stock
- Ratings Hubei Wanrun New Energy Technology Co.,Ltd.